BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/4/2020 9:56:59 AM | Browse: 1135 | Download: 2341
 |
Received |
|
2020-08-28 18:31 |
|
Peer-Review Started |
|
2020-08-28 18:31 |
|
First Decision by Editorial Office Director |
|
2020-09-29 18:25 |
|
Return for Revision |
|
2020-09-29 18:25 |
|
Revised |
|
2020-10-03 12:44 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-10-19 08:46 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-10-20 03:11 |
|
Articles in Press |
|
2020-10-20 03:11 |
|
Edit the Manuscript by Language Editor |
|
2020-11-02 00:33 |
|
Typeset the Manuscript |
|
2020-12-01 07:49 |
|
Publish the Manuscript Online |
|
2020-12-04 09:56 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Retrospective Study |
| Article Title |
Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hong-Ming Zhu, Yan Li, Bang-Yi Li, Shuang Yang, Ding Peng, Xiaojiao Yang, Xue-Lian Sun and Mei Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mei Zhang, MD, Chief Physician, Occupational Physician, Professor, Department of Gastroenterology, Xuanwu Hospital of Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing 100053, China. zhang2955@sina.com |
| Key Words |
COVID-19; Glucocorticoids; Methylprednisolone; Cytokine storm; Coronavirus infections; Cytokines |
| Core Tip |
Glucocorticoids were used in the treatment of severe acute respiratory syndrome, influenza A and coronavirus disease 2019 (COVID-19) in the past. Many studies believe that glucocorticoids can effectively reduce inflammation caused by viruses. In this manuscript, 102 patients with severe and critical COVID-19 were studied and divided into treatment group and control group according to methylprednisolone use. We found that the difference in mortality between both groups was insignificant (P = 0.655), and the results showed that methylprednisolone treatment did not improve prognosis. |
| Publish Date |
2020-12-04 09:56 |
| Citation |
Zhu HM, Li Y, Li BY, Yang S, Peng D, Yang X, Sun XL, Zhang M. Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases. World J Clin Cases 2020; 8(23): 5952-5961 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i23/5952.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i23.5952 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
